Intelligent Bio Solutions Files 8-K
Ticker: INBS · Form: 8-K · Filed: Feb 7, 2025 · CIK: 1725430
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
IBSI filed an 8-K on Feb 7, 2025, with Reg FD and financial updates.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on February 7, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as GBS Inc., is incorporated in Delaware and headquartered in New York City.
Why It Matters
This filing provides updates on company disclosures and financial statements, which are crucial for investors to understand the company's current status and regulatory compliance.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, indicating standard corporate reporting rather than a significant event.
Key Numbers
- 001-39825 — SEC File Number (Identifies the company's filing with the SEC.)
- 82-1512711 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Intelligent Bio Solutions Inc. (company) — Registrant
- GBS Inc. (company) — Former company name
- February 7, 2025 (date) — Date of Report
- New York (location) — Principal executive offices city
- Delaware (location) — State of Incorporation
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, covering Regulation FD Disclosure and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on February 7, 2025.
What were the previous names of Intelligent Bio Solutions Inc.?
Intelligent Bio Solutions Inc. was formerly known as GBS Inc. and prior to that, Glucose Biosensor Systems (Greater China) Holdings, Inc.
Where are the principal executive offices of Intelligent Bio Solutions Inc. located?
The principal executive offices are located at 135 West 41st Street, 5th Floor, New York, NY 10036.
In which state is Intelligent Bio Solutions Inc. incorporated?
Intelligent Bio Solutions Inc. is incorporated in Delaware.
Filing Stats: 527 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-02-07 17:30:34
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 35KB
- ex99-1.htm (EX-99.1) — 21KB
- ex99-1_001.jpg (GRAPHIC) — 286KB
- ex99-1_002.jpg (GRAPHIC) — 248KB
- ex99-1_003.jpg (GRAPHIC) — 32KB
- ex99-1_004.jpg (GRAPHIC) — 249KB
- ex99-1_005.jpg (GRAPHIC) — 235KB
- 0001493152-25-005469.txt ( ) — 1680KB
- inbs-20250207.xsd (EX-101.SCH) — 3KB
- inbs-20250207_lab.xml (EX-101.LAB) — 33KB
- inbs-20250207_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 7, 2025 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer